Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Baldini C et al. – The presence or absence of ANCA–MPO identify different clinical subsets in CSS. Overall, ANCA–MPO appears as a useful tool in the monitoring of CSS and in particular a good predictor of CSS relapses.

Related Articles

Churg-Strauss syndrome: evidence for disease subtypes?
Current Opinion in Rheumatology, 10/26/09    Relevance Score: 67%

Therapeutic Angiogenesis by Controlled-Release Fibroblast Growth Factor in a Patient With Churg-Strauss Syndrome Complicated by an Intractable Ischemic Leg Ulcer
The American Journal of the Medical Sciences, 10/20/09    Relevance Score: 67%

Churg-Strauss syndrome successfully treated with rituximab
Rheumatology International, 10/15/09    Relevance Score: 67%

Diagnostic and therapeutic management of Churg-Strauss syndrome
Expert Review of Clinical Immunology, 11/24/09    Relevance Score: 65%

Recent progress in the genetics of Wegeners granulomatosis and Churg-Strauss syndrome
Current Opinion in Rheumatology, 10/30/09    Relevance Score: 64%

Today in Vasculitic Syndromes...keeping you current

HIV-associated Intracranial Aneurysmal Vasculopathy in Adults
Journal of Rheumatology, 12/17/09

QT interval dispersion in North Indian children with Kawasaki disease without overt coronary artery abnormalities
Rheumatology International, 12/16/09

Predictors of Damage and Survival in Patients with Wegener's Granulomatosis: Analysis of 50 Patients
Journal of Rheumatology, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address